Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population

NCT00259077 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-erosive Reflux Disease

Interventions

DRUG: Omeprazole

Sponsor

AstraZeneca

Collaborators

[object Object]